No Pharma Money
News & Reports
News November 25, 2019

The Week in Review in Prescription Drug Pricing

By P4ADNow Team

1. We Could Do This For So Much Less

  • Letting academic medical centers make CAR-T drugs would save billions. — (STAT Op-Ed)

2. Betrayal

  • Doctors who were instrumental in developing a groundbreaking heart drug are now decrying its exorbitant price tag. — (Bloomberg)

3. Forced to Buy High

  • While generic drugs are seeing approvals in record number, these drugs are increasingly experiencing delays when it comes to reaching patients. — (The Wall Street Journal)

4. “Most new drugs aren’t that innovative.”

  • Big Pharma’s biggest argument for maintaining high prescription prices is full of cracks. — (The Hill)

5. Congress, Please Wake Up

  • America wants lower drug prices. How many times and in how many ways and with how many polls can we say this???? — (Kaiser Family Foundation)

Stay Connected

Stay informed about the latest campaigns, policy developments, and ways to help lower prescription drug prices.